DM Nathan, J Lachin, P Cleary, The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group ,Intensive diabetes therapy and carotid intima-media thickness in type-1 diabetes mellitus N Engl J Med 348 (2003) 2294 2303.

Retinopathy and Nephropathy in Patients

Retinopathy and Nephropathy in Patients with Type 1 Diabetes Four Years after A Trial of Intensive Insulin Therapy,: by The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. N Engl J Med 342:381–9, 2000

✍ Charles C Barr 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 74 KB

Use of the Michigan Neuropathy Screening

Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications

✍ W. H. Herman; R. Pop-Busui; B. H. Braffett; C. L. Martin; P. A. Cleary; J. W. Al 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB

Use of the Michigan Neuropathy Screening

Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications

✍ W. H. Herman; R. Pop-Busui; B. H. Braffett; C. L. Martin; P. A. Cleary; J. W. Al 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB

Diabet. Med. 29, 937–944 (2012) ## Abstract **Aims** The Michigan Neuropathy Screening Instrument (MNSI) is used to assess distal symmetrical peripheral neuropathy in diabetes. It includes two separate assessments: a 15‐item self‐administered questionnaire and a lower extremity examination that in